menopause and microdosing glp 1 the Long Term Benefits for Women: Shamsah Amersi, MD: OB-GYNs GLP-1 Weight Loss in Menopause:

Key timeline for Eli Lillys orforglipron: The approval of the first oral GLP-1 pill for weight loss expands the treatment landscape for obesity

Tracking your shots can help reduce this and make the journey more enjoyable

Interestingly, research suggests that GLP-1 may be impaired in some people with obesity, even if they have a normal glucose tolerance

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D 2

GLP-1 drugs such as semaglutide delay gastric emptying and suppress appetite, which can leave you feeling full for longer and can cause constipation and bloating